US and Europe Injectable Drug Delivery Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Devices Type (Conventional Drug Delivery Devices and Advanced Drug Delivery Devices), Formulation (Conventional Drug Delivery, Novel Drug Delivery, and Long Acting Injectable Formulations), Formulation Packaging (Ready-to-use ampoules, Vials, Cartridges, and Bottles), Therapeutic Application (Diabetes, Oncology, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases, Pain Management, and Other Therapeutic Applications), Usability (Disposable Injectors and Reusable Injectors), Route Of Administration (Sub-cutaneous, Intramuscular, Intravenous and Other Route of Administrations), End User (Pharmaceutical and Biopharma Companies and CMOs and CDMOs), and Geography
The US and Europe injectable drug delivery market size is expected to grow from US$ 27.17 billion in 2024 to US$ 46.74 billion by 2031; it is projected to register a CAGR of 8.2% during 2025-2031. The rising prevalence of diabetes and demand for self-administered biologics, advancements in oncology and biologics requiring precision delivery, and expansion in autoimmune and cardiovascular disease management are noteworthy factors contributing to the expansion of the US and Europe injectable drug delivery market size. Additionally, the rising focus on biologics and personalized medicine is projected to bring new US and Europe injectable drug delivery market trends in the near future.
The US and Europe are putting more and more weight on biologics and personalized medicine, things that have a great impact on the injectable drug delivery market. Biologic therapies, which include monoclonal antibodies and gene therapies among others, although not cheap, are gaining acceptance due to their potency in dealing with extremely difficult diseases such as cancer and autoimmune disorders. To be precise, in the year 2023, the US FDA gave the green light to more than 50 biologic drugs, and the majority of them had already been utilizing specialized delivery systems that allow for multidose pens and connected injectors. On the other hand, according to the EMA, the European market experienced a 12% rise in biologic approvals from 2022 to 2023. Meanwhile, one important aspect of the drug delivery technology is the smart injectors, which come with digital connectivity and are able to monitor dosage and adherence, thus improving patient outcomes. Among the recent developments that have taken place in this field is the launching of smart auto-injectors by companies such as Amgen and Novo Nordisk in 2024, where the technology has IoT capabilities for real-time monitoring. In an effort to keep being innovative, the governments have provided financial support and set up regulatory pathways that simplify the approval processes for advanced delivery devices. The growth of personalized medicine has led to the need for injection systems that are flexible, efficient, and patient-friendly, which in turn forces the companies to continue their R&D investments. This drift signifies a move towards more customized, technology-driven injectable solutions in both markets, thereby emerging as a significant trend in the US and Europe injectable drug delivery market.
End User-Based Insights
Based on end user, the US and Europe injectable drug delivery market is segmented into pharmaceutical and biopharma companies and CMOs and CDMOs. The pharmaceutical and biopharma companies segment held a larger US and Europe injectable drug delivery market share in 2024. The injectable drug delivery market of the US and Europe has mainly the pharmaceutical and biopharmaceutical companies as the end-users who support innovation and volume. Large multi-nationals and biotech firms are increasingly defining combination products, pre-filled syringes, autoinjectors, on-body injectors, and cartridge-based pens to secure lifecycle differentiation and favorable formulary positioning during clinical development. In the US, partnerships with device manufacturers start at Phase II so as to satisfy the FDA combination product requirements and to have the Design History Files support both drug and device approvals. European drug sponsors utilize the EU MDR Article 117 to incorporate Notified Body Opinions at the very beginning, thus speeding up the subcutaneous oncology and immunology programs. Both regions have the same focus on platform technologies (for instance, 2.25 mL autoinjectors, and 3 mL cartridges), which allow quick line extensions and new products from biosimilars. The gradual increase in the number of high-concentration biologics is directly responsible for the investment in advanced primary containers (COC/COP barrels and silicone-free systems) and filling lines with 100% in-process control capability that is fully monitored. Also, biopharma companies support the digital health integrations—Bluetooth dose logging, adherence apps, and recycling programs—with the purpose of producing real-world evidence and meeting the expectations of payers in both the US and Europe, thereby fueling the US and Europe injectable drug delivery market growth.
The Centers for Disease Control and Prevention and National Institutes of Health are among the primary and secondary sources referred to while preparing the US and Europe injectable drug delivery market report.
Reason to buy
The US and Europe are putting more and more weight on biologics and personalized medicine, things that have a great impact on the injectable drug delivery market. Biologic therapies, which include monoclonal antibodies and gene therapies among others, although not cheap, are gaining acceptance due to their potency in dealing with extremely difficult diseases such as cancer and autoimmune disorders. To be precise, in the year 2023, the US FDA gave the green light to more than 50 biologic drugs, and the majority of them had already been utilizing specialized delivery systems that allow for multidose pens and connected injectors. On the other hand, according to the EMA, the European market experienced a 12% rise in biologic approvals from 2022 to 2023. Meanwhile, one important aspect of the drug delivery technology is the smart injectors, which come with digital connectivity and are able to monitor dosage and adherence, thus improving patient outcomes. Among the recent developments that have taken place in this field is the launching of smart auto-injectors by companies such as Amgen and Novo Nordisk in 2024, where the technology has IoT capabilities for real-time monitoring. In an effort to keep being innovative, the governments have provided financial support and set up regulatory pathways that simplify the approval processes for advanced delivery devices. The growth of personalized medicine has led to the need for injection systems that are flexible, efficient, and patient-friendly, which in turn forces the companies to continue their R&D investments. This drift signifies a move towards more customized, technology-driven injectable solutions in both markets, thereby emerging as a significant trend in the US and Europe injectable drug delivery market.
End User-Based Insights
Based on end user, the US and Europe injectable drug delivery market is segmented into pharmaceutical and biopharma companies and CMOs and CDMOs. The pharmaceutical and biopharma companies segment held a larger US and Europe injectable drug delivery market share in 2024. The injectable drug delivery market of the US and Europe has mainly the pharmaceutical and biopharmaceutical companies as the end-users who support innovation and volume. Large multi-nationals and biotech firms are increasingly defining combination products, pre-filled syringes, autoinjectors, on-body injectors, and cartridge-based pens to secure lifecycle differentiation and favorable formulary positioning during clinical development. In the US, partnerships with device manufacturers start at Phase II so as to satisfy the FDA combination product requirements and to have the Design History Files support both drug and device approvals. European drug sponsors utilize the EU MDR Article 117 to incorporate Notified Body Opinions at the very beginning, thus speeding up the subcutaneous oncology and immunology programs. Both regions have the same focus on platform technologies (for instance, 2.25 mL autoinjectors, and 3 mL cartridges), which allow quick line extensions and new products from biosimilars. The gradual increase in the number of high-concentration biologics is directly responsible for the investment in advanced primary containers (COC/COP barrels and silicone-free systems) and filling lines with 100% in-process control capability that is fully monitored. Also, biopharma companies support the digital health integrations—Bluetooth dose logging, adherence apps, and recycling programs—with the purpose of producing real-world evidence and meeting the expectations of payers in both the US and Europe, thereby fueling the US and Europe injectable drug delivery market growth.
The Centers for Disease Control and Prevention and National Institutes of Health are among the primary and secondary sources referred to while preparing the US and Europe injectable drug delivery market report.
Reason to buy
- Saves and reduces time required for identifying the market growth, size, leading players, and segments in the US and Europe Injectable Drug Delivery market.
- Highlights key business priorities to assist companies in realigning their business strategies
- Emphasizes key findings and recommendations that uncover emerging industry trends in the US and Europe Injectable Drug Delivery market, enabling stakeholders across the value chain to craft effective long-term strategies
- Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
- Scrutinizes in-depth US and Europe Injectable Drug Delivery market trends, along with factors driving the market, as well as those hindering it
- Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
2.3 Overview
2.4 Value Chain Analysis
2.4.1 US and Europe Injectable Drug Delivery Market – Value Chain Analysis
2.4.2 Raw Material Suppliers / Components
2.4.3 Manufacturers Process / Technology
2.4.4 Distribution Landscape
2.5 Supply Chain Analysis
2.5.1 List of Service Providers
2.5.2 List of Potential Customers
2.6 Porter`s Five Force Analysis
2.7 PEST Analysis
2.8 Product/Technology Roadmap
2.9 Sustainability and ESG Trends
2.9.1 Environmental Trends
2.9.2 Social Trends
2.9.3 Governance Trends
2.10 Regulatory Framework and Pipeline Analysis
3. COMPETITIVE LANDSCAPE
3.1 Company Benchmarking by Key Players
3.2 US and Europe Market Share Analysis, 2024 – By 10 Key Players
3.3 Competitors Analysis - 15 Key Players US and Europe
3.4 Competitors Analysis - 5 Key Players in the US
3.5 US and Europe Pricing Analysis - 10 Key Players
3.6 Market Concentration
3.7 Market Trends Affecting GLP-1 Therapies and Their Impact on the Pen Business (3–5 Year Outlook)
3.7.1 Expansion of Oral Formulations Reducing Pen Dependency
3.7.2 Smart Pens and Digital Integration Enhancing Adherence
3.7.3 Supply Chain Pressures and Pen Manufacturing Expansion
4. RESEARCH METHODOLOGY
4.1 Secondary Research
4.2 Primary Research
4.2.1 Hypothesis formulation:
4.2.2 Macro-economic factor analysis:
4.2.3 Developing base number:
4.2.4 Data Triangulation:
4.2.5 Country level data:
5. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Europe Injectable Drug Delivery Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Diabetes and Demand for Self-Administered Biologics
5.2.2 Advancements in Oncology and Biologics Requiring Precision Delivery
5.2.3 Expansion in Auto-Immune and Cardiovascular Disease Management
5.3 Market Restraints
5.3.1 High risk of drug shortages and supply-chain disruptions
5.3.2 Regulatory, manufacturing-complexity and quality/safety burdens
5.3.3 Competition from alternative drug delivery methods & declining injectable demand among certain user groups
5.4 Market Opportunities
5.4.1 Rising Approvals of Biologics and Novel Drugs
5.4.2 Growth of Rare-Disease and Specialty Therapies
5.4.3 Regulatory Support and Innovation Momentum
5.5 Future Trends
5.5.1 Increasing Adoption of Prefilled and Auto-Injectors
5.5.2 Rising Focus on Biologics and Personalized Medicine
5.5.3 Emphasis on Sustainability and Reusable Injection Devices
5.6 Impact of Drivers and Restraints:
6. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS
6.1 US and Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
6.2 US and Europe Injectable Drug Delivery Market Forecast and Analysis
7. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY DEVICES TYPE
7.1 Conventional Drug Delivery Devices
7.1.1 Overview
7.1.2 Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Advanced Drug Delivery Devices
7.2.1 Overview
7.2.2 Advanced Drug Delivery Devices: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.3 Prefilled Syringes
7.2.3.1 Overview
7.2.3.2 Prefilled Syringes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.4 Pen Injectors
7.2.4.1 Overview
7.2.4.2 Pen Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.5 Auto-Injectors
7.2.5.1 Overview
7.2.5.2 Auto-Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.6 Needle-Free Injectors
7.2.6.1 Overview
7.2.6.2 Needle-Free Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.7 Wearable Injectors
7.2.7.1 Overview
7.2.7.2 Wearable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.8 Other Drug Delivery Device Types
7.2.8.1 Overview
7.2.8.2 Other Drug Delivery Device Types: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY FORMULATION
8.1 Conventional Drug Delivery
8.1.1 Overview
8.1.2 Conventional Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.3 Solutions
8.1.3.1 Solutions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.4 Reconstituted or Lyophilized formulations
8.1.4.1 Overview
8.1.4.2 Reconstituted or Lyophilized formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.5 Suspensions
8.1.5.1 Overview
8.1.5.2 Suspensions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.6 Emulsion
8.1.6.1 Overview
8.1.6.2 Emulsion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Novel Drug Delivery
8.2.1 Overview
8.2.2 Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.1 Colloidal Dispersion
8.2.2.1.1 Overview
8.2.2.1.2 Colloidal Dispersion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.2 Microparticles
8.2.2.2.1 Overview
8.2.2.2.2 Microparticles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.3 Other Novel Drug Delivery
8.2.2.3.1 Overview
8.2.2.3.2 Other Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Long Acting Injectable Formulations
8.3.1 Overview
8.3.2 Long Acting Injectable Formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY FORMULATION PACKAGING (READY-TO-USE)
9.1 Ampoules
9.1.1 Overview
9.1.2 Ampoules: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vials
9.2.1 Overview
9.2.2 Vials: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Cartridges
9.3.1 Overview
9.3.2 Cartridges: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Bottles
9.4.1 Overview
9.4.2 Bottles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY THERAPEUTIC APPLICATION
10.1 Diabetes
10.1.1 Overview
10.1.2 Diabetes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Oncology
10.2.1 Overview
10.2.2 Oncology: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Auto-Immune Disorders
10.3.1 Overview
10.3.2 Auto-Immune Disorders: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Cardiovascular Diseases
10.4.1 Overview
10.4.2 Cardiovascular Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Diseases
10.5.1 Overview
10.5.2 Infectious Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Pain Management
10.6.1 Overview
10.6.2 Pain Management: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Other Therapeutic Applications
10.7.1 Overview
10.7.2 Other Therapeutic Applications: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY USABILITY
11.1 Disposable Injectors
11.1.1 Overview
11.1.2 Disposable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Re-usable Injectors
11.2.1 Overview
11.2.2 Re-usable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
12.1 Sub-cutaneous
12.1.1 Overview
12.1.2 Sub-cutaneous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.2 Intramuscular
12.2.1 Overview
12.2.2 Intramuscular: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Intravenous
12.3.1 Overview
12.3.2 Intravenous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Other Route of Administrations
12.4.1 Overview
12.4.2 Other Route of Administrations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY END USER
13.1 Pharmaceutical and Biopharma Companies
13.1.1 Overview
13.1.2 Pharmaceutical and Biopharma Companies: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13.2 CMOs and CDMOs
13.2.1 Overview
13.2.2 CMOs and CDMOs: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET – COUNTRY ANALYSIS
14.1 Europe
14.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.2 United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.2.1 United States: Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.2.2 United States: Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.2.3 United States: Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.2.4 United States: Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.2.5 United States: Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.2.6 United States: Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.2.7 United States: Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.2.8 United States: Injectable Drug Delivery Market Breakdown by Usability
14.1.1.2.9 United States: Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.2.10 United States: Injectable Drug Delivery Market Breakdown by End User
14.1.1.3 Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.3.1 Germany: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.3.2 Germany: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.3.3 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.3.4 Germany: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.3.5 Germany: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.3.6 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.3.7 Germany: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.3.8 Germany: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.3.9 Germany: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.3.10 Germany: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.4 United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.4.1 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.4.2 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.4.3 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.4.4 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.4.5 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.4.6 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.4.7 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.4.8 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.4.9 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.4.10 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.5 France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.5.1 France: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.5.2 France: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.5.3 France: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.5.4 France: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.5.5 France: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.5.6 France: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.5.7 France: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.5.8 France: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.5.9 France: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.5.10 France: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.6 Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.6.1 Spain: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.6.2 Spain: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.6.3 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.6.4 Spain: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.6.5 Spain: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.6.6 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.6.7 Spain: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.6.8 Spain: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.6.9 Spain: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.6.10 Spain: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.7 Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.7.1 Italy: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.7.2 Italy: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.7.3 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.7.4 Italy: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.7.5 Italy: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.7.6 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.7.7 Italy: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.7.8 Italy: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.7.9 Italy: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.7.10 Italy: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.8 Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.8.1 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.8.2 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.8.3 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.8.4 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.8.5 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.8.6 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.8.7 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.8.8 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.8.9 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.8.10 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by End User
15. INDUSTRY LANDSCAPE
15.1 Overview
15.2 Market Initiative
15.3 Merger and Acquisition
15.4 Other Development
16. COMPANY PROFILES
16.1 Cardinal Health Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Becton Dickinson and Co
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Schott AG
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 B Braun SE
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Terumo Corp
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Phillips-Medisize
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Nipro Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Gerresheimer AG
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Kindeva Drug Delivery LP
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 West Pharmaceutical Services Inc
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
17.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
2.3 Overview
2.4 Value Chain Analysis
2.4.1 US and Europe Injectable Drug Delivery Market – Value Chain Analysis
2.4.2 Raw Material Suppliers / Components
2.4.3 Manufacturers Process / Technology
2.4.4 Distribution Landscape
2.5 Supply Chain Analysis
2.5.1 List of Service Providers
2.5.2 List of Potential Customers
2.6 Porter`s Five Force Analysis
2.7 PEST Analysis
2.8 Product/Technology Roadmap
2.9 Sustainability and ESG Trends
2.9.1 Environmental Trends
2.9.2 Social Trends
2.9.3 Governance Trends
2.10 Regulatory Framework and Pipeline Analysis
3. COMPETITIVE LANDSCAPE
3.1 Company Benchmarking by Key Players
3.2 US and Europe Market Share Analysis, 2024 – By 10 Key Players
3.3 Competitors Analysis - 15 Key Players US and Europe
3.4 Competitors Analysis - 5 Key Players in the US
3.5 US and Europe Pricing Analysis - 10 Key Players
3.6 Market Concentration
3.7 Market Trends Affecting GLP-1 Therapies and Their Impact on the Pen Business (3–5 Year Outlook)
3.7.1 Expansion of Oral Formulations Reducing Pen Dependency
3.7.2 Smart Pens and Digital Integration Enhancing Adherence
3.7.3 Supply Chain Pressures and Pen Manufacturing Expansion
4. RESEARCH METHODOLOGY
4.1 Secondary Research
4.2 Primary Research
4.2.1 Hypothesis formulation:
4.2.2 Macro-economic factor analysis:
4.2.3 Developing base number:
4.2.4 Data Triangulation:
4.2.5 Country level data:
5. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET – KEY MARKET DYNAMICS
5.1 Europe Injectable Drug Delivery Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Diabetes and Demand for Self-Administered Biologics
5.2.2 Advancements in Oncology and Biologics Requiring Precision Delivery
5.2.3 Expansion in Auto-Immune and Cardiovascular Disease Management
5.3 Market Restraints
5.3.1 High risk of drug shortages and supply-chain disruptions
5.3.2 Regulatory, manufacturing-complexity and quality/safety burdens
5.3.3 Competition from alternative drug delivery methods & declining injectable demand among certain user groups
5.4 Market Opportunities
5.4.1 Rising Approvals of Biologics and Novel Drugs
5.4.2 Growth of Rare-Disease and Specialty Therapies
5.4.3 Regulatory Support and Innovation Momentum
5.5 Future Trends
5.5.1 Increasing Adoption of Prefilled and Auto-Injectors
5.5.2 Rising Focus on Biologics and Personalized Medicine
5.5.3 Emphasis on Sustainability and Reusable Injection Devices
5.6 Impact of Drivers and Restraints:
6. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS
6.1 US and Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
6.2 US and Europe Injectable Drug Delivery Market Forecast and Analysis
7. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY DEVICES TYPE
7.1 Conventional Drug Delivery Devices
7.1.1 Overview
7.1.2 Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Advanced Drug Delivery Devices
7.2.1 Overview
7.2.2 Advanced Drug Delivery Devices: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.3 Prefilled Syringes
7.2.3.1 Overview
7.2.3.2 Prefilled Syringes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.4 Pen Injectors
7.2.4.1 Overview
7.2.4.2 Pen Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.5 Auto-Injectors
7.2.5.1 Overview
7.2.5.2 Auto-Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.6 Needle-Free Injectors
7.2.6.1 Overview
7.2.6.2 Needle-Free Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.7 Wearable Injectors
7.2.7.1 Overview
7.2.7.2 Wearable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2.8 Other Drug Delivery Device Types
7.2.8.1 Overview
7.2.8.2 Other Drug Delivery Device Types: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY FORMULATION
8.1 Conventional Drug Delivery
8.1.1 Overview
8.1.2 Conventional Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.3 Solutions
8.1.3.1 Solutions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.4 Reconstituted or Lyophilized formulations
8.1.4.1 Overview
8.1.4.2 Reconstituted or Lyophilized formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.5 Suspensions
8.1.5.1 Overview
8.1.5.2 Suspensions: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.1.6 Emulsion
8.1.6.1 Overview
8.1.6.2 Emulsion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Novel Drug Delivery
8.2.1 Overview
8.2.2 Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.1 Colloidal Dispersion
8.2.2.1.1 Overview
8.2.2.1.2 Colloidal Dispersion: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.2 Microparticles
8.2.2.2.1 Overview
8.2.2.2.2 Microparticles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.2.2.3 Other Novel Drug Delivery
8.2.2.3.1 Overview
8.2.2.3.2 Other Novel Drug Delivery: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Long Acting Injectable Formulations
8.3.1 Overview
8.3.2 Long Acting Injectable Formulations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY FORMULATION PACKAGING (READY-TO-USE)
9.1 Ampoules
9.1.1 Overview
9.1.2 Ampoules: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vials
9.2.1 Overview
9.2.2 Vials: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Cartridges
9.3.1 Overview
9.3.2 Cartridges: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Bottles
9.4.1 Overview
9.4.2 Bottles: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY THERAPEUTIC APPLICATION
10.1 Diabetes
10.1.1 Overview
10.1.2 Diabetes: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Oncology
10.2.1 Overview
10.2.2 Oncology: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Auto-Immune Disorders
10.3.1 Overview
10.3.2 Auto-Immune Disorders: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Cardiovascular Diseases
10.4.1 Overview
10.4.2 Cardiovascular Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Diseases
10.5.1 Overview
10.5.2 Infectious Diseases: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Pain Management
10.6.1 Overview
10.6.2 Pain Management: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Other Therapeutic Applications
10.7.1 Overview
10.7.2 Other Therapeutic Applications: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY USABILITY
11.1 Disposable Injectors
11.1.1 Overview
11.1.2 Disposable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Re-usable Injectors
11.2.1 Overview
11.2.2 Re-usable Injectors: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
12.1 Sub-cutaneous
12.1.1 Overview
12.1.2 Sub-cutaneous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.2 Intramuscular
12.2.1 Overview
12.2.2 Intramuscular: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Intravenous
12.3.1 Overview
12.3.2 Intravenous: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Other Route of Administrations
12.4.1 Overview
12.4.2 Other Route of Administrations: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET ANALYSIS – BY END USER
13.1 Pharmaceutical and Biopharma Companies
13.1.1 Overview
13.1.2 Pharmaceutical and Biopharma Companies: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
13.2 CMOs and CDMOs
13.2.1 Overview
13.2.2 CMOs and CDMOs: US and Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14. US AND EUROPE INJECTABLE DRUG DELIVERY MARKET – COUNTRY ANALYSIS
14.1 Europe
14.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.1 US and Europe Injectable Drug Delivery Market Revenue and Forecast and Analysis – by Country
14.1.1.2 United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.2.1 United States: Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.2.2 United States: Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.2.3 United States: Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.2.4 United States: Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.2.5 United States: Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.2.6 United States: Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.2.7 United States: Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.2.8 United States: Injectable Drug Delivery Market Breakdown by Usability
14.1.1.2.9 United States: Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.2.10 United States: Injectable Drug Delivery Market Breakdown by End User
14.1.1.3 Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.3.1 Germany: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.3.2 Germany: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.3.3 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.3.4 Germany: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.3.5 Germany: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.3.6 Germany: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.3.7 Germany: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.3.8 Germany: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.3.9 Germany: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.3.10 Germany: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.4 United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.4.1 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.4.2 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.4.3 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.4.4 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.4.5 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.4.6 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.4.7 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.4.8 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.4.9 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.4.10 United Kingdom: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.5 France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.5.1 France: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.5.2 France: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.5.3 France: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.5.4 France: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.5.5 France: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.5.6 France: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.5.7 France: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.5.8 France: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.5.9 France: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.5.10 France: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.6 Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.6.1 Spain: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.6.2 Spain: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.6.3 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.6.4 Spain: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.6.5 Spain: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.6.6 Spain: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.6.7 Spain: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.6.8 Spain: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.6.9 Spain: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.6.10 Spain: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.7 Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.7.1 Italy: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.7.2 Italy: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.7.3 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.7.4 Italy: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.7.5 Italy: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.7.6 Italy: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.7.7 Italy: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.7.8 Italy: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.7.9 Italy: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.7.10 Italy: Europe Injectable Drug Delivery Market Breakdown by End User
14.1.1.8 Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
14.1.1.8.1 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Devices Type
14.1.1.8.2 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Advanced Drug Delivery Device Types
14.1.1.8.3 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation
14.1.1.8.4 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Conventional Drug Delivery Types
14.1.1.8.5 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Novel Drug Delivery
14.1.1.8.6 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Formulation Packaging (ready-to-use)
14.1.1.8.7 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Therapeutic Application
14.1.1.8.8 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Usability
14.1.1.8.9 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by Route Of Administration
14.1.1.8.10 Rest of Europe: Europe Injectable Drug Delivery Market Breakdown by End User
15. INDUSTRY LANDSCAPE
15.1 Overview
15.2 Market Initiative
15.3 Merger and Acquisition
15.4 Other Development
16. COMPANY PROFILES
16.1 Cardinal Health Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Becton Dickinson and Co
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Schott AG
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 B Braun SE
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Terumo Corp
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Phillips-Medisize
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Nipro Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Gerresheimer AG
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Kindeva Drug Delivery LP
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 West Pharmaceutical Services Inc
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. APPENDIX
17.1 About The Insight Partners
17.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Injectable Drug Delivery Market Segmentation
Table 2. List of Service Providers
Table 3. List of Potential Customers
Table 4. List of Regulatory Bodies and Organizations
Table 5. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Table 6. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 7. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 8. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 9. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 10. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 11. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 12. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 13. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 14. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 15. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 16. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 17. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 18. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 19. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 20. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 21. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 22. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 23. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 24. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 25. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 27. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 28. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 29. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 30. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 31. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 32. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 33. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 34. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 35. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 36. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 37. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 38. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 39. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 40. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 41. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 42. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 43. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 44. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 45. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 46. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 47. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 48. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 49. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 50. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 51. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 52. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 53. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 55. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 56. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 57. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 58. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 59. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 60. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 61. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 62. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 63. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 64. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 65. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 66. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 67. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 68. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 69. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 70. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 71. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 72. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 73. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 74. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 75. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 76. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 77. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 78. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 79. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 80. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 81. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 82. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 83. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 84. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 85. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 1. Europe Injectable Drug Delivery Market Segmentation
Table 2. List of Service Providers
Table 3. List of Potential Customers
Table 4. List of Regulatory Bodies and Organizations
Table 5. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Table 6. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 7. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 8. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 9. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 10. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 11. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 12. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 13. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 14. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 15. Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 16. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 17. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 18. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 19. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 20. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 21. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 22. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 23. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 24. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 25. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 27. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 28. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 29. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 30. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 31. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 32. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 33. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 34. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 35. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 36. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 37. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 38. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 39. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 40. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 41. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 42. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 43. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 44. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 45. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 46. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 47. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 48. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 49. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 50. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 51. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 52. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 53. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 55. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 56. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 57. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 58. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 59. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 60. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 61. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 62. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 63. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 64. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 65. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 66. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 67. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 68. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 69. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 70. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 71. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 72. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 73. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 74. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 75. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 76. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Devices Type
Table 77. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Advanced Drug Delivery Device Types
Table 78. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation
Table 79. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Conventional Drug Delivery Types
Table 80. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Novel Drug Delivery
Table 81. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Formulation Packaging (ready-to-use)
Table 82. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 83. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Usability
Table 84. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 85. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million) – by End User
LIST OF FIGURES
Figure 1. Europe Injectable Drug Delivery Market Segmentation, by Country
Figure 2. Porter's Five Forces Analysis
Figure 3. PEST Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
Figure 6. Europe Injectable Drug Delivery Market Share (%) – by Devices Type, 2024 and 2031
Figure 7. Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. Advanced Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 9. Prefilled Syringes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pen Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Auto-Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Needle-Free Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 13. Wearable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 14. Other Drug Delivery Device Types: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Europe Injectable Drug Delivery Market Share (%) – by Formulation, 2024 and 2031
Figure 16. Conventional Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 17. Solutions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 18. Reconstituted or Lyophilized formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Suspensions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. Emulsion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 21. Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Colloidal Dispersion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Microparticles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. Other Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 25. Long Acting Injectable Formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 26. Europe Injectable Drug Delivery Market Share (%) – by Formulation Packaging (ready-to-use), 2024 and 2031
Figure 27. Ampoules: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 28. Vials: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 29. Cartridges: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 30. Bottles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 31. Europe Injectable Drug Delivery Market Share (%) – by Therapeutic Application, 2024 and 2031
Figure 32. Diabetes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 33. Oncology: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 34. Auto-Immune Disorders: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 35. Cardiovascular Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 36. Infectious Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 37. Pain Management: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 38. Other Therapeutic Applications: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 39. Europe Injectable Drug Delivery Market Share (%) – by Usability, 2024 and 2031
Figure 40. Disposable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 41. Re-usable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 42. Europe Injectable Drug Delivery Market Share (%) – by Route Of Administration, 2024 and 2031
Figure 43. Sub-cutaneous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 44. Intramuscular: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 45. Intravenous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 46. Other Route of Administrations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 47. Europe Injectable Drug Delivery Market Share (%) – by End User, 2024 and 2031
Figure 48. Pharmaceutical and Biopharma Companies: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 49. CMOs and CDMOs: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 50. Europe Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 51. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 52. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 53. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 55. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 56. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 57. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 58. Glossary of Terms, Human Albumin Market
Figure 1. Europe Injectable Drug Delivery Market Segmentation, by Country
Figure 2. Porter's Five Forces Analysis
Figure 3. PEST Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Injectable Drug Delivery Market Revenue (US$ Million), 2021–2031
Figure 6. Europe Injectable Drug Delivery Market Share (%) – by Devices Type, 2024 and 2031
Figure 7. Conventional Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. Advanced Drug Delivery Devices: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 9. Prefilled Syringes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pen Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Auto-Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Needle-Free Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 13. Wearable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 14. Other Drug Delivery Device Types: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Europe Injectable Drug Delivery Market Share (%) – by Formulation, 2024 and 2031
Figure 16. Conventional Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 17. Solutions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 18. Reconstituted or Lyophilized formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Suspensions: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. Emulsion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 21. Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Colloidal Dispersion: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Microparticles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. Other Novel Drug Delivery: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 25. Long Acting Injectable Formulations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 26. Europe Injectable Drug Delivery Market Share (%) – by Formulation Packaging (ready-to-use), 2024 and 2031
Figure 27. Ampoules: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 28. Vials: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 29. Cartridges: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 30. Bottles: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 31. Europe Injectable Drug Delivery Market Share (%) – by Therapeutic Application, 2024 and 2031
Figure 32. Diabetes: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 33. Oncology: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 34. Auto-Immune Disorders: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 35. Cardiovascular Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 36. Infectious Diseases: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 37. Pain Management: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 38. Other Therapeutic Applications: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 39. Europe Injectable Drug Delivery Market Share (%) – by Usability, 2024 and 2031
Figure 40. Disposable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 41. Re-usable Injectors: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 42. Europe Injectable Drug Delivery Market Share (%) – by Route Of Administration, 2024 and 2031
Figure 43. Sub-cutaneous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 44. Intramuscular: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 45. Intravenous: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 46. Other Route of Administrations: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 47. Europe Injectable Drug Delivery Market Share (%) – by End User, 2024 and 2031
Figure 48. Pharmaceutical and Biopharma Companies: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 49. CMOs and CDMOs: Europe Injectable Drug Delivery Market– Revenue and Forecast to 2031 (US$ Million)
Figure 50. Europe Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 51. United States: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 52. Germany: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 53. United Kingdom: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 54. France: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 55. Spain: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 56. Italy: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 57. Rest of Europe: Europe Injectable Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 58. Glossary of Terms, Human Albumin Market
